Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep;22(3):200-211.
doi: 10.1016/S1441-2772(23)00387-3.

Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy

Alberto Zangrillo  1 , Luigi Beretta  1 , Anna Mara Scandroglio  1 , Giacomo Monti  1 , Evgeny Fominskiy  1 , Sergio Colombo  1 , Federica Morselli  1 , Alessandro Belletti  1 , Paolo Silvani  1 , Martina Crivellari  1 , Fabrizio Monaco  1 , Maria Luisa Azzolini  1 , Raffaella Reineke  1 , Pasquale Nardelli  1 , Marianna Sartorelli  1 , Carmine D Votta  1 , Annalisa Ruggeri  1 , Fabio Ciceri  2 , Francesco De Cobelli  2 , Moreno Tresoldi  3 , Lorenzo Dagna  2 , Patrizia Rovere-Querini  2 , Ary Serpa Neto  4 , Rinaldo Bellomo  4 , Giovanni Landoni  5 ; COVID-BioB Study Group
Affiliations

Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy

Alberto Zangrillo et al. Crit Care Resusc. 2020 Sep.

Abstract

Objective: Describe characteristics, daily care and outcomes of patients with coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS).

Design: Case series of 73 patients.

Setting: Large tertiary hospital in Milan.

Participants: Mechanically ventilated patients with confirmed COVID-19 admitted to the intensive care unit (ICU) between 20 February and 2 April 2020.

Main outcome measures: Demographic and daily clinical data were collected to identify predictors of early mortality.

Results: Of the 73 patients included in the study, most were male (83.6%), the median age was 61 years (interquartile range [IQR], 54-69 years), and hypertension affected 52.9% of patients. Lymphocytopenia (median, 0.77 x 103 per mm3; IQR, 0.58-1.00 x 103 per mm3), hyperinflammation with C-reactive protein (median, 184.5 mg/dL; IQR, 108.2-269.1 mg/dL) and pro-coagulant status with D-dimer (median, 10.1 μg/m; IQR, 5.0-23.8 μg/m) were present. Median tidal volume was 6.7 mL/kg (IQR, 6.0-7.5 mL/kg), and median positive end-expiratory pressure was 12 cmH2O (IQR, 10-14 cmH2O). In the first 3 days, prone positioning (12-16 h) was used in 63.8% of patients and extracorporeal membrane oxygenation in five patients (6.8%). After a median follow-up of 19.0 days (IQR, 15.0-27.0 days), 17 patients (23.3%) had died, 23 (31.5%) had been discharged from the ICU, and 33 (45.2%) were receiving invasive mechanical ventilation in the ICU. Older age (odds ratio [OR], 1.12; 95% CI, 1.04-1.22; P = 0.004) and hypertension (OR, 6.15; 95% CI, 1.75-29.11; P = 0.009) were associated with mortality, while early improvement in arterial partial pressure of oxygen (PaO2) to fraction of inspired oxygen (FiO2) ratio was associated with being discharged alive from the ICU (P = 0.002 for interaction).

Conclusions: Despite multiple advanced critical care interventions, COVID-19 ARDS was associated with prolonged ventilation and high short term mortality. Older age and pre-admission hypertension were key mortality risk factors.

Trial registration: ClinicalTrials.gov identifier: NCT04318366.

PubMed Disclaimer

Conflict of interest statement

Lorenzo Dagna received consultation honoraria from Roche, Sanofi-Genzyme and SOBI outside of the submitted work. Ary Serpa Neto reported receiving personal fees from Dräger outside of the submitted work.

Figures

Figure 1
Figure 1
Kaplan–Meier curves for 7-day mortality (A) and cumulative incidence function of extubation and intensive care unit mortality (B)* * Data were censored at the latest follow-up (2 April 2020).
Figure 2
Figure 2
Effect of changes in Pao2/Fio2 ratio in the first 7 days on mortality and on the chance of being discharged alive from the intensive care unit (ICU) at the latest follow-up Fio2 = fraction of inspired oxygen; Pao2 = arterial partial pressure of oxygen. Panel A shows the change in the Pao2/Fio2 ratio in the first 7 days of follow-up compared with the baseline value and according to survival at the latest follow-up. Panel B shows the change in the Pao2/Fio2 ratio in the first 7 days of follow-up compared with the baseline value and according to being discharged alive from the ICU at the latest follow-up. In both plots, circles are medians and the error bars represent the interquartile range (IQR); the P value represents the interaction between the groups and the days from an unadjusted mixed-effect quantile regression based on the asymmetric Laplace distribution for continuous variables and accounting for the repeated measurements. The median difference for the interaction is 4.19 (IQR, –2.10 to 10.50; P = 0.186) for the comparison of survivors and non-survivors, and 9.64 (IQR, 3.68–15.59; P = 0.002) for the comparison of being discharged alive or not. Panel C shows a marginal effect plot with the effect of changes in the Pao2/Fio2 ratio at Day 3 on the predicted risk of mortality at the longest follow-up from a univariable generalised linear model considering a binomial distribution. The odds ratio for the change is 0.99 (95% CI, 0.99–1.00; P = 0.441). Panel D shows a marginal effect plot with the effect of changes in the Pao2/Fio2 ratio at Day 3 on the predicted risk of being discharged alive from the ICU at the longest follow-up from a univariable generalised linear model considering a binomial distribution. The odds ratio for the change is 1.01 (95% CI, 0.99–1.02; P = 0.071).
See this image and copyright information in PMC

Similar articles

  • Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A; COVID-19 Lombardy ICU Network. Grasselli G, et al. JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394. JAMA. 2020. PMID: 32250385 Free PMC article.
  • Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, Bonanomi E, Cabrini L, Carlesso E, Castelli G, Cattaneo S, Cereda D, Colombo S, Coluccello A, Crescini G, Forastieri Molinari A, Foti G, Fumagalli R, Iotti GA, Langer T, Latronico N, Lorini FL, Mojoli F, Natalini G, Pessina CM, Ranieri VM, Rech R, Scudeller L, Rosano A, Storti E, Thompson BT, Tirani M, Villani PG, Pesenti A, Cecconi M; COVID-19 Lombardy ICU Network. Grasselli G, et al. JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539. JAMA Intern Med. 2020. PMID: 32667669 Free PMC article.
  • SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria.
    Barrasa H, Rello J, Tejada S, Martín A, Balziskueta G, Vinuesa C, Fernández-Miret B, Villagra A, Vallejo A, San Sebastián A, Cabañes S, Iribarren S, Fonseca F, Maynar J; Alava COVID-19 Study Investigators. Barrasa H, et al. Anaesth Crit Care Pain Med. 2020 Oct;39(5):553-561. doi: 10.1016/j.accpm.2020.04.001. Epub 2020 Apr 9. Anaesth Crit Care Pain Med. 2020. PMID: 32278670 Free PMC article.
  • Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy.
    Toniati P, Piva S, Cattalini M, Garrafa E, Regola F, Castelli F, Franceschini F, Airò P, Bazzani C, Beindorf EA, Berlendis M, Bezzi M, Bossini N, Castellano M, Cattaneo S, Cavazzana I, Contessi GB, Crippa M, Delbarba A, De Peri E, Faletti A, Filippini M, Filippini M, Frassi M, Gaggiotti M, Gorla R, Lanspa M, Lorenzotti S, Marino R, Maroldi R, Metra M, Matteelli A, Modina D, Moioli G, Montani G, Muiesan ML, Odolini S, Peli E, Pesenti S, Pezzoli MC, Pirola I, Pozzi A, Proto A, Rasulo FA, Renisi G, Ricci C, Rizzoni D, Romanelli G, Rossi M, Salvetti M, Scolari F, Signorini L, Taglietti M, Tomasoni G, Tomasoni LR, Turla F, Valsecchi A, Zani D, Zuccalà F, Zunica F, Focà E, Andreoli L, Latronico N. Toniati P, et al. Autoimmun Rev. 2020 Jul;19(7):102568. doi: 10.1016/j.autrev.2020.102568. Epub 2020 May 3. Autoimmun Rev. 2020. PMID: 32376398 Free PMC article. Review.
  • Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.
    Suleyman G, Fadel RA, Malette KM, Hammond C, Abdulla H, Entz A, Demertzis Z, Hanna Z, Failla A, Dagher C, Chaudhry Z, Vahia A, Abreu Lanfranco O, Ramesh M, Zervos MJ, Alangaden G, Miller J, Brar I. Suleyman G, et al. JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270. JAMA Netw Open. 2020. PMID: 32543702 Free PMC article. Review.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. Lu H., Stratton C.W., Tang Y.W. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. J Med Virol. 2020;92:401–402. - PMC - PubMed
    1. Hui D.S., Azhar E.I., Madani T.A., et al. The continuing 2019nCoV epidemic threat of novel coronaviruses to global health — the latest 2019 novel coronavirus outbreak in Wuhan. China. Int J Infect Dis. 2020;91:264–266. - PMC - PubMed
    1. Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. - PMC - PubMed
    1. Arentz M., Yim E., Klaff L., et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA. 2020 doi: 10.1001/jama.2020.4326. [Epub ahead of print] - DOI - PMC - PubMed
    1. Bhatraju P.K., Ghassemieh B.J., Nichols M., et al. Covid-19 in critically ill patients in the Seattle region — case series. N Engl J Med. 2020 doi: 10.1056/NEJMoa2004500. [Epub ahead of print] - DOI - PMC - PubMed

MeSH terms

Associated data

  NODES
INTERN 3
twitter 2